Jose E Rivera has sold NTLA and made no open-market buys since May 2020
EVP and General Counsel at Intellia Therapeutics, Inc.
SEC CIK 0001671870 · Filings on SEC.gov ↗
Every filing
13 filings since May 2020, newest first
Intellia Therapeutics, Inc.
EVP and General Counsel
Intellia Therapeutics, Inc.
EVP and General Counsel
Intellia Therapeutics, Inc.
EVP and General Counsel
Intellia Therapeutics, Inc.
EVP and General Counsel
Intellia Therapeutics, Inc.
EVP and General Counsel
Intellia Therapeutics, Inc.
EVP and General Counsel
Intellia Therapeutics, Inc.
EVP and General Counsel
Intellia Therapeutics, Inc.
EVP and General Counsel
Intellia Therapeutics, Inc.
EVP and General Counsel
Intellia Therapeutics, Inc.
EVP and General Counsel
Intellia Therapeutics, Inc.
EVP and General Counsel
Intellia Therapeutics, Inc.
EVP and General Counsel
Intellia Therapeutics, Inc.
EVP and General Counsel
Filings come from SEC EDGAR. Not investment advice.